These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 15572556)

  • 21. Safety of budesonide/formoterol maintenance and reliever therapy in asthma trials.
    Sears MR; Radner F
    Respir Med; 2009 Dec; 103(12):1960-8. PubMed ID: 19815402
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Relative effectiveness of budesonide/formoterol and fluticasone propionate/salmeterol in a 1-year, population-based, matched cohort study of patients with chronic obstructive pulmonary disease (COPD): Effect on COPD-related exacerbations, emergency department visits and hospitalizations, medication utilization, and treatment adherence.
    Blais L; Forget A; Ramachandran S
    Clin Ther; 2010 Jul; 32(7):1320-8. PubMed ID: 20678680
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Budesonide/formoterol combination therapy as both maintenance and reliever medication in asthma.
    O'Byrne PM; Bisgaard H; Godard PP; Pistolesi M; Palmqvist M; Zhu Y; Ekström T; Bateman ED
    Am J Respir Crit Care Med; 2005 Jan; 171(2):129-36. PubMed ID: 15502112
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Asthma control can be maintained after fixed-dose, budesonide/ formoterol combination inhaler therapy is stepped down from medium to low dose.
    Hojo M; Mizutani T; Iikura M; Hirano S; Kobayashi N; Sugiyama H
    Allergol Int; 2013 Mar; 62(1):91-8. PubMed ID: 23093793
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Efficacy and safety of high-dose budesonide/formoterol (Symbicort) compared with budesonide administered either concomitantly with formoterol or alone in patients with persistent symptomatic asthma.
    Jenkins C; Kolarikova R; Kuna P; Caillaud D; Sanchis J; Popp W; Pettersson E
    Respirology; 2006 May; 11(3):276-86. PubMed ID: 16635085
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Fast onset of effect of budesonide/formoterol versus salmeterol/fluticasone and salbutamol in patients with chronic obstructive pulmonary disease and reversible airway obstruction.
    Lindberg A; Szalai Z; Pullerits T; Radeczky E
    Respirology; 2007 Sep; 12(5):732-9. PubMed ID: 17875063
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Treatment of persistent asthma with Symbicort (budesonide/formoterol inhalation aerosol): an inhaled corticosteroid and long-acting beta2-adrenergic agonist in one pressurized metered-dose inhaler.
    Berger WE; Noonan MJ
    J Asthma; 2010 May; 47(4):447-59. PubMed ID: 20528601
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Formoterol (Perforomist) for COPD.
    Med Lett Drugs Ther; 2007 Nov; 49(1274):94-5. PubMed ID: 18007544
    [No Abstract]   [Full Text] [Related]  

  • 29. Overall asthma control: the relationship between current control and future risk.
    Bateman ED; Reddel HK; Eriksson G; Peterson S; Ostlund O; Sears MR; Jenkins C; Humbert M; Buhl R; Harrison TW; Quirce S; O'Byrne PM
    J Allergy Clin Immunol; 2010 Mar; 125(3):600-8, 608.e1-608.e6. PubMed ID: 20153029
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Budesonide/formoterol in a single inhaler versus inhaled corticosteroids alone in the treatment of asthma.
    Tal A; Simon G; Vermeulen JH; Petru V; Cobos N; Everard ML; de Boeck K
    Pediatr Pulmonol; 2002 Nov; 34(5):342-50. PubMed ID: 12357478
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Budesonide-formoterol combination inhaler.
    Beever R
    Can Fam Physician; 2008 Aug; 54(8):1109-10; author reply 1110-1. PubMed ID: 18697968
    [No Abstract]   [Full Text] [Related]  

  • 32. Budesonide/formoterol maintenance and reliever therapy: a new treatment approach for adult patients with asthma.
    Buhl R; Vogelmeier C
    Curr Med Res Opin; 2007 Aug; 23(8):1867-78. PubMed ID: 17605896
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Triple therapy in chronic obstructive pulmonary disease].
    Baloira A
    Arch Bronconeumol; 2010; 46 Suppl 8():25-30. PubMed ID: 21334553
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Efficacy and safety of budesonide/formoterol via a dry powder inhaler in Chinese patients with chronic obstructive pulmonary disease.
    Zhong N; Zheng J; Wen F; Yang L; Chen P; Xiu Q; Yao W; Sun T; Zhao Z; Shen H; Shi Y; Lin J; Li Q
    Curr Med Res Opin; 2012 Feb; 28(2):257-65. PubMed ID: 22046961
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Beta agonist use during asthma exacerbations: how much is too much?
    Patel M; Perrin K; Beasley R
    N Z Med J; 2011 Apr; 124(1332):77-80. PubMed ID: 21747427
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Scientific rationale for using a single inhaler for asthma control.
    Barnes PJ
    Eur Respir J; 2007 Mar; 29(3):587-95. PubMed ID: 17329493
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comparative effectiveness of budesonide/formoterol and fluticasone/salmeterol for COPD management.
    Roberts M; Mapel D; Petersen H; Blanchette C; Ramachandran S
    J Med Econ; 2011; 14(6):769-76. PubMed ID: 21942463
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effect on lung function and morning activities of budesonide/formoterol versus salmeterol/fluticasone in patients with COPD.
    Partridge MR; Schuermann W; Beckman O; Persson T; Polanowski T
    Ther Adv Respir Dis; 2009 Aug; 3(4):1-11. PubMed ID: 19734176
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The use of inhaled formoterol in the treatment of asthma.
    Berger WE
    Ann Allergy Asthma Immunol; 2006 Jul; 97(1):24-33. PubMed ID: 16892777
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Efficacy and safety of budesonide/formoterol dry powder inhalation for treatment of childhood asthma].
    He MQ; Zhu HG
    Zhongguo Dang Dai Er Ke Za Zhi; 2009 Sep; 11(9):767-8. PubMed ID: 19755031
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.